DNA amplified by PCR revealed that the electrophoretic pattern had shifted in 30 cases; sequence analysis confirmed the occurrence of a mutation in 29 cases and of a polymorphism in one. In 27 cases both assays gave a positive result, and in 40 both were negative; therefore, concordance between PCR-SSCP and immunohistochemistry was seen in 72% of cases. Conclusion-The data indicate that positive immunostaining corresponds with the presence of a mutation in most, but not all, cases studied; other mechanisms could be responsible for stabilisation and accumulation of p53 protein in the nucleus. Nonsense mutations which do not confer stability on the protein will not be detected by immunohistochemistry and false negative results can also occur with SSCP analysis. Several genetic alterations have been shown to play a significant role in tumorigenesis. By and large, the most frequently observed molecular changes occur in the p53 gene.' The p53 gene encodes a protein involved in control of the cell cycle, which is capable of binding to DNA and acts as a negative regulator in the cell's response to damaged DNA.2
Functional alteration of p53 protein can occur through several mechanisms: point mutations, deletions, and rearrangements in the p53 gene; binding with viral proteins (for example, SV40 T antigen, adenovirus Elb, papillomavirus E6); binding with cellular proteins (for example, mdm-2 oncoprotein, heat shock proteins); and oligomerisation.' Wild-type p53 protein has a very short half-life, whereas mutated p53 is stable and can accumulate at high concentrations in the nuclei of tumour cells. As a consequence, immunohistochemical staining with specific antibodies can be used to detect mutant p53 protein. However, p53 overexpression can also reflect the accumulation of wild-type protein that has been stabilised via a mechanism other than mutation-for example, by binding with SV40 T antigen, which greatly increases the half-life of the protein. 4 The detection of p53 protein by immunohistochemistry is simple, can be applied to both frozen and archival tissues, and has been used extensively in the study of tumour Sections with nuclear staining in less than 10% of the tumour cells were regarded as negative, those with staining in 10% to 25% of cells were scored +, those with staining in 25% to 75% were scored + +, and those with staining in over 75% were scored + ++.
P53 MUTATION ANALYSIS
Extraction of DNA To obtain genomic DNA, sections of frozen tissue 20 .tm thick were digested overnight at 37°C with proteinase K in TNE buffer (10 mM Tris, 100 mM NaCl, 1 mM EDTA) and sodium dodecylsulphate, and then extracted with phenol/chloroform; DNA was precipitated with 1/10 volume 3 M sodium acetate (pH 5 0) and two volumes of cold absolute ethanol (-20°C), washed with 70% ethanol, air dried, and redissolved in distilled water. In some cases DNA was extracted from formalin fixed, paraffin wax embedded material as described by Levi et al.23 PCR-SSCP p53 gene mutations were detected b, PCR-SSCP analysis of exons 5 to 8 as described previously.'8 Briefly, 25 amplification cycles were carried out in a DNA thermal cycler 90r% (Perkin Elmer, Norwalk, Connecticut, USA) followed by five further "hot" cycles with 1 uCi alpha "P-dATP. Annealing temperatures were 60°C (exons 5 and 6), 560C (exon 7) and 51°C (exon 8). The amplified products were denatured in formamide loading buffer (95% formamide, 20 mM EDTA, 0 05% xylene cyanol, 0 05% bromophenol blue) and run at 30W on a 6% polyacrylamide gel containing 5% glycerol. The gel was then dried and exposed to x ray film at -800C for 12 to 48 hours.
Direct DNA sequencing Shifted bands were eluted from the gel, amplified by PCR incorporating a phosphorylated primer, and digested with lambda exonuclease to convert the double stranded PCR product to a single stranded form. Other reaction components were removed from the template both prior to and following digestion by using Micro Spin columns containing Sephacryl S-400 HR resin (Pharmacia Biotech, Piscataway, New Jersey, USA).
DNA was then sequenced by the Sanger dideoxy chain termination method24 using the "fmol DNA sequencing system" (Promega Corporation, Madison, Wisconsin, USA). 
Results
discordant results were an occasional finding) in the present study, cytoplasmic reactivity was a rare finding and could be interpreted as an artefact (rather than a real accumulation of p53 protein outside the nucleus).
It is important to establish the minimum number of stained neoplastic cells needed to regard a tumour sample as positive. Because the number of stained cells required for a positive result varies from study to study, the results obtained by different groups are difficult to compare. Indeed, for some workers one or a few positive cells are indicative of a positive sample, while we and others" 1519 require a minimum of 5-10% stained cells for a positive result to avoid the possibility of false positive reactions due to background staining or artefacts. In the present study, many tumour samples which scored as + or + + on staining with PAb 1801 antibody became + + or + + + with BP53-12-1. Thus, the phenotypic pattern of the tumour could depend on the sensitivity and specificity of the antibody used, and therefore correlation of the phenotypic pattern with the presence and type of mutation, or even with patient prognosis and outcome would be arbitrary.
A comparison of PCR-SSCP and immunohistochemical findings showed concordant results in 72-0% of our cases. In particular, 27 (93-1 %) of the 29 cases showing a p53 gene mutation were also positive for p53 protein accumulation on immunohistochemistry, while 24 (37 5%) of the 64 cases without mutations were positive on immunohistochemistry. In 26 (28 0%) cases the immunohistochemical and SSCP results were discordant; negative immunohistochemistry/positive SSCP in two, and positive immunohistochemistry/negative SSCP in 24. On sequencing, the two cases with a p53 mutation on SSCP analysis and no immunohistochemical staining had a nonsense mutation which resulted in the substitution of a coding triplet by a stop signal at codons 165 (exon 5) and 306 (exon 8), respectively. In both cases, the encoded protein was truncated at the C-terminal region, and lacked the nuclear localisation signal I (residues 312-323) essential for its transport to the nucleus.2526 Sequence analysis of DNA from normal and tumour tissue in the case with the polymorphism at codon 213 in exon 6 showed a silent CGA to CGG transition (arginine to arginine), and the normal p53 protein produced did not accumulate in the cell.27 As the SSCP screening method does not distinguish polymorphisms from mutations, sequence analysis is necessary to clarify the significance of the altered electrophoretic pattern.
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